A precision-medicine protocol for treating acromegaly can slash healthcare costs by 22% while more than doubling a patient’s chances of reaching hormonal remission, according to an economic analysis of the ACROFAST clinical trial. “Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study,” a Spanish study recently published in the...
On behalf of the Endocrine Society’s Early-Career Special Interest Group, Maria Andrea Camilletti, PhD, takes us on a guided journey from family influences to how she developed such a keen interest in the pituitary, and explains why it brings her so much joy. As a child, I knew I wanted to be a scientist without...
The JCEM Case Reports Clinical Pearls session at ENDO 2025 featured three presentations of rare challenging endocrine cases that could answer questions for endocrinologists who could be treating patients with similar symptoms, possibly triggering further investigations that might lead to optimal outcomes. The audience for the third-annual JCEM Case Reports Clinical Pearls session at ENDO...
Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare...
Despite successful medical intervention, people with acromegaly don’t always share their clinician’s optimistic outlook. Eliza B. Geer, MD, director of Memorial Sloan Kettering’s Multidisciplinary Pituitary & Skull Base Tumor Center, takes us through a holistic approach to treating this often-confounding condition and how a team-based methodology is frequently the key to success. Recently, I was...
Always mystifying and bit mysterious, the pituitary is the gland that sends out the orders to the other glands in the body, from regulating the adrenals and the thyroid to coordinating reproduction. However, thanks to a worldwide collaboration and a new database, this “master gland” is slowly but surely unlocking its secrets. The pituitary –...
In two sessions focusing on pituitary tumors at next month’s CEU 2022, neurosurgeon Gabriel Zada, MD, MS, FAANS, FACS, will discuss advances in new surgical techniques and inpatient and long-term management, and give an in-depth overview of managing patients with pituitary adenomas. In addition, he will elucidate how health disparities can often have an even...
Positive results from the Phase III LINC 4 study have confirmed the efficacy and safety of osilodrostat, an oral therapy for patients with Cushing’s disease. The results were published in The Journal of Clinical Endocrinology & Metabolism. Recordati Rare Diseases is marketing the drug as ISTURISA®. The LINC 4 study augments the efficacy and safety...
Despite successful medical intervention, people with acromegaly don’t always share their clinician’s optimistic outlook. Eliza B. Geer, MD, director of Memorial Sloan Kettering’s Multidisciplinary Pituitary & Skull Base Tumor Center, takes us through a holistic approach to treating this often-confounding condition and how a team-based methodology is frequently the key to success. Recently, I was...
In two sessions focusing on pituitary tumors at next month’s CEU 2022, neurosurgeon Gabriel Zada, MD, MS, FAANS, FACS, will discuss advances in new surgical techniques and inpatient and long-term management, and give an in-depth overview of managing patients with pituitary adenomas. In addition, he will elucidate how health disparities can often have an even...
